Phase 1/1B trial to assess the activity of entrectinib in children and adolescents with recurrent or refractory solid tumors including central nervous system (CNS) tumors Meeting Abstract
| Authors: | Robinson, G. W.; Gajjar, A. J.; Gauvain, K. M.; Basu, E. M.; Macy, M. E.; Maese, L. D.; Sabnis, A. J.; Foster, J. H.; Shusterman, S.; Yoon, J.; Weiss, B. D.; Abdelbaki, M.; Farid-Kapadia, M.; Meneses-Lorente, G.; Cardenas, A.; Hutchinson, K.; Bergthold, G.; Maneval, E. C.; Fox, E.; Desai, A. V. |
| Abstract Title: | Phase 1/1B trial to assess the activity of entrectinib in children and adolescents with recurrent or refractory solid tumors including central nervous system (CNS) tumors |
| Meeting Title: | 55th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2019 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-05-20 |
| Start Page: | 537s |
| Language: | English |
| ACCESSION: | WOS:000487345803597 |
| DOI: | 10.1200/JCO.2019.37.15_suppl.10009 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 10009 -- Source: Wos |
